RDY 353 Pill - brown capsule/oblong, 17mm
Pill with imprint RDY 353 is Brown, Capsule/Oblong and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Dr. Reddy's Laboratories Ltd.
Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RDY 353
Rivastigmine Tartrate
- Imprint
- RDY 353
- Strength
- 3 mg
- Color
- Brown
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories Ltd.
- National Drug Code (NDC)
- 55111-0353
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (5 mPa.s),
magnesium stearate,
microcrystalline cellulose,
gelatin,
titanium dioxide,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
- Rivastigmine Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
